Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition - PubMed (original) (raw)
Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition
Christer Busch et al. Hum Pathol. 2002 Mar.
Abstract
Many cancers have altered expression of various cell adhesion molecules. One of these is CEACAM1, which has been found to be downregulated in several carcinomas, including prostate cancer. We explored its immunohistochemical expression in a set of 64 total prostatectomy specimens and compared it with that of the epithelial cell adhesion molecule E-cadherin and occludin, a tight junction-associated molecule. The luminal surface of the epithelial cells of normal prostate glands and ducts showed a dense expression of CEACAM1. This pattern prevailed in prostate cancer of Gleason grades 1 to 3 as long as the cells maintained their polarity and formed individual glands. With "fusion" of glands (ie, in the transition to Gleason grade 4), the expression of CEACAM1 was lost in polygonal nonpolar cells and was lost or focally very weak in cells lining a lumen in the cribriform complexes. E-cadherin, which outlined the basolateral cell membranes of contacting neighboring epithelial cells was also downregulated in prostate carcinomas. However, the loss of E-cadherin expression in higher grades was gradual and not related to the Gleason 3 to >4 transition. Occludin was also lost in polygonal (ie, unpolarized) cells of Gleason grades 4 and 5, but remained expressed in all cells facing a lumen in all grades of cancer, which CEACAM1 was not. In conclusion, downregulation of CEACAM1 as well as that of occludin in prostate cancer is associated with loss of cell polarity. It coincides with the formation of the complex glandular architecture of Gleason grade 4 pattern or complete loss thereof in Gleason grade 5 patterns. The proliferative activity, measured as Ki67 labeling index, showed a fourfold increase in the carcinoma cells with lost CEACAM1 expression, supporting previous observations that CEACAM1 regulates cell proliferation. Immunohistochemical analysis of CEACAM1 expression patterns may be useful in assessment of the malignant potential of prostate carcinoma.
Copyright 2002, Elsevier Science (USA). All rights reserved.
Similar articles
- Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers.
Luebke AM, Ricken W, Kluth M, Hube-Magg C, Schroeder C, Büscheck F, Möller K, Dum D, Höflmayer D, Weidemann S, Fraune C, Hinsch A, Wittmer C, Schlomm T, Huland H, Heinzer H, Graefen M, Haese A, Minner S, Simon R, Sauter G, Wilczak W, Meiners J. Luebke AM, et al. Int J Cancer. 2020 Jul 15;147(2):575-583. doi: 10.1002/ijc.32957. Epub 2020 Mar 18. Int J Cancer. 2020. PMID: 32150281 - Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L, Rowland RG, Lele SM, Kyprianou N. Zeng L, et al. Hum Pathol. 2004 Mar;35(3):290-7. doi: 10.1016/j.humpath.2003.11.001. Hum Pathol. 2004. PMID: 15017584 - High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
Zhao J, Epstein JI. Zhao J, et al. Am J Surg Pathol. 2009 Apr;33(4):583-90. doi: 10.1097/PAS.0b013e31818a5c6c. Am J Surg Pathol. 2009. PMID: 19033862 - Cell-cell adhesion molecule CEACAM1 is expressed in normal breast and milk and associates with beta1 integrin in a 3D model of morphogenesis.
Kirshner J, Hardy J, Wilczynski S, Shively JE. Kirshner J, et al. J Mol Histol. 2004 Mar;35(3):287-99. doi: 10.1023/b:hijo.0000032360.01976.81. J Mol Histol. 2004. PMID: 15339048 Free PMC article. Review. - The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA; Grading Committee. Epstein JI, et al. Am J Surg Pathol. 2016 Feb;40(2):244-52. doi: 10.1097/PAS.0000000000000530. Am J Surg Pathol. 2016. PMID: 26492179 Review.
Cited by
- Clinical and experimental studies regarding the expression and diagnostic value of carcinoembryonic antigen-related cell adhesion molecule 1 in non-small-cell lung cancer.
Zhou MQ, Du Y, Liu YW, Wang YZ, He YQ, Yang CX, Wang WJ, Gao F. Zhou MQ, et al. BMC Cancer. 2013 Jul 25;13:359. doi: 10.1186/1471-2407-13-359. BMC Cancer. 2013. PMID: 23885995 Free PMC article. - Different expression of occludin and ZO-1 in primary and metastatic liver tumors.
Orbán E, Szabó E, Lotz G, Kupcsulik P, Páska C, Schaff Z, Kiss A. Orbán E, et al. Pathol Oncol Res. 2008 Sep;14(3):299-306. doi: 10.1007/s12253-008-9031-2. Epub 2008 Apr 2. Pathol Oncol Res. 2008. PMID: 18386163 - Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma.
Wang L, Jin X, Lin D, Liu Z, Zhang X, Lu Y, Liu Y, Wang M, Yang M, Li J, Quan C. Wang L, et al. Diagn Pathol. 2013 Nov 19;8:190. doi: 10.1186/1746-1596-8-190. Diagn Pathol. 2013. PMID: 24245968 Free PMC article. - CEACAM Gene Family Mutations Associated With Inherited Breast Cancer Risk - A Comparative Oncology Approach to Discovery.
Huskey ALW, McNeely I, Merner ND. Huskey ALW, et al. Front Genet. 2021 Aug 10;12:702889. doi: 10.3389/fgene.2021.702889. eCollection 2021. Front Genet. 2021. PMID: 34447411 Free PMC article. - Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology.
Jumper N, Hodgkinson T, Paus R, Bayat A. Jumper N, et al. PLoS One. 2017 Mar 3;12(3):e0172955. doi: 10.1371/journal.pone.0172955. eCollection 2017. PLoS One. 2017. PMID: 28257480 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous